REPORTS

Let’s Pullulate and Expand Your Business

Global Biologics and Biosimilars Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 14, 2020  |  217 PAGES  |  REPORT CODE: CMM365094
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

The Biologics and Biosimilars is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period. The research provides insights for the global Biologics and Biosimilars market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Biologics and Biosimilars industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Biologics and Biosimilars Market Segmentations:

By Players:

  • Roche

  • Amgen

  • AbbVie

  • Sanofi-Aventis

  • Johnson & Johnson

  • Pfizer

  • Novo Nordisk

  • Eli Lilly

  • Novartis

  • Merck

  • 3sbio

  • Changchun High Tech

  • CP Guojian

  • Biotech

  • Gelgen

  • Innovent

  • Dong Bao

  • Ganlee

  • United Laboratories

By Types:

  • Antibody

  • Hormone

  • Growth Factors

  • Others

By End-User:

  • Tumor

  • Diabetes

  • Cardiovascular

  • Hemophilia

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics and Biosimilars Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Biologics and Biosimilars Market Size and Growth Rate of Antibody from 2014 to 2026

    • 1.3.2 Global Biologics and Biosimilars Market Size and Growth Rate of Hormone from 2014 to 2026

    • 1.3.3 Global Biologics and Biosimilars Market Size and Growth Rate of Growth Factors from 2014 to 2026

    • 1.3.4 Global Biologics and Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Biologics and Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

    • 1.4.2 Global Biologics and Biosimilars Market Size and Growth Rate of Diabetes from 2014 to 2026

    • 1.4.3 Global Biologics and Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • 1.4.4 Global Biologics and Biosimilars Market Size and Growth Rate of Hemophilia from 2014 to 2026

    • 1.4.5 Global Biologics and Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Biologics and Biosimilars Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Biologics and Biosimilars Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Biologics and Biosimilars by Major Types

    • 3.4.1 Biologics and Biosimilars Market Size and Growth Rate of Antibody

    • 3.4.2 Biologics and Biosimilars Market Size and Growth Rate of Hormone

    • 3.4.3 Biologics and Biosimilars Market Size and Growth Rate of Growth Factors

    • 3.4.4 Biologics and Biosimilars Market Size and Growth Rate of Others

4 Segmentation of Biologics and Biosimilars Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Biologics and Biosimilars by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Biologics and Biosimilars in Tumor

    • 4.4.2 Market Size and Growth Rate of Biologics and Biosimilars in Diabetes

    • 4.4.3 Market Size and Growth Rate of Biologics and Biosimilars in Cardiovascular

    • 4.4.4 Market Size and Growth Rate of Biologics and Biosimilars in Hemophilia

    • 4.4.5 Market Size and Growth Rate of Biologics and Biosimilars in Others

5 Market Analysis by Major Regions

  • 5.1 Global Biologics and Biosimilars Production Analysis by Major Regions

  • 5.2 Global Biologics and Biosimilars Consumption Analysis by Major Regions

  • 5.3 Global Biologics and Biosimilars Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Biologics and Biosimilars Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Biologics and Biosimilars Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Biologics and Biosimilars Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Biologics and Biosimilars Production, Import, Consumption and Export Analysis

6 Product Commodity of Biologics and Biosimilars Market in Major Countries

  • 6.1 Top 5 Export Countries in Biologics and Biosimilars market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Biologics and Biosimilars market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Biologics and Biosimilars market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Biologics and Biosimilars market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Biologics and Biosimilars market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Biologics and Biosimilars market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Biologics and Biosimilars Landscape Analysis

  • 7.1 North America Biologics and Biosimilars Landscape Analysis by Major Types

  • 7.2 North America Biologics and Biosimilars Landscape Analysis by Major End-Users

  • 7.3 North America Biologics and Biosimilars Landscape Analysis by Major Countries

    • 7.3.1 United States Biologics and Biosimilars Market Volume and Growth Rate

    • 7.3.2 Canada Biologics and Biosimilars Market Volume and Growth Rate

    • 7.3.3 Mexico Biologics and Biosimilars Market Volume and Growth Rate

8 Europe Biologics and Biosimilars Landscape Analysis

  • 8.1 Europe Biologics and Biosimilars Landscape Analysis by Major Types

  • 8.2 Europe Biologics and Biosimilars Landscape Analysis by Major End-Users

  • 8.3 Europe Biologics and Biosimilars Landscape Analysis by Major Countries

    • 8.3.1 Germany Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.2 UK Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.3 France Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.4 Italy Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.6 Spain Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.7 Belgium Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.8 Poland Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.9 Russia Biologics and Biosimilars Market Volume and Growth Rate

    • 8.3.10 Turkey Biologics and Biosimilars Market Volume and Growth Rate

9 Asia Pacific Biologics and Biosimilars Landscape Analysis

  • 9.1 Asia Pacific Biologics and Biosimilars Landscape Analysis by Major Types

  • 9.2 Asia Pacific Biologics and Biosimilars Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Biologics and Biosimilars Landscape Analysis by Major Countries

    • 9.3.1 China Biologics and Biosimilars Market Volume and Growth Rate

    • 9.3.2 Japan Biologics and Biosimilars Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Biologics and Biosimilars Market Volume and Growth Rate

    • 9.3.4 India Biologics and Biosimilars Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Biologics and Biosimilars Market Volume and Growth Rate

    • 9.3.6 South Korea Biologics and Biosimilars Market Volume and Growth Rate

10 Latin America, Middle East & Africa Biologics and Biosimilars Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Biologics and Biosimilars Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Biologics and Biosimilars Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Biologics and Biosimilars Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Biologics and Biosimilars Market Volume and Growth Rate

    • 10.3.2 Brazil Biologics and Biosimilars Market Volume and Growth Rate

    • 10.3.3 Nigeria Biologics and Biosimilars Market Volume and Growth Rate

    • 10.3.4 South Africa Biologics and Biosimilars Market Volume and Growth Rate 

    • 10.3.5 Argentina Biologics and Biosimilars Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Roche

    • 11.1.1 Roche Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Amgen

    • 11.2.1 Amgen Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 AbbVie

    • 11.3.1 AbbVie Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Sanofi-Aventis

    • 11.4.1 Sanofi-Aventis Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Johnson & Johnson

    • 11.5.1 Johnson & Johnson Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Pfizer

    • 11.6.1 Pfizer Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Novo Nordisk

    • 11.7.1 Novo Nordisk Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Eli Lilly

    • 11.8.1 Eli Lilly Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Novartis

    • 11.9.1 Novartis Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Merck

    • 11.10.1 Merck Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 3sbio

    • 11.11.1 3sbio Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Changchun High Tech

    • 11.12.1 Changchun High Tech Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 CP Guojian

    • 11.13.1 CP Guojian Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Biotech

    • 11.14.1 Biotech Company Profile and Recent Development

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Gelgen

    • 11.15.1 Gelgen Company Profile and Recent Development

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Innovent

    • 11.16.1 Innovent Company Profile and Recent Development

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Dong Bao

    • 11.17.1 Dong Bao Company Profile and Recent Development

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Ganlee

    • 11.18.1 Ganlee Company Profile and Recent Development

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 United Laboratories

    • 11.19.1 United Laboratories Company Profile and Recent Development

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 84 Figures and 205 Tables)

  • Figure Product Picture

  • Figure Biologics and Biosimilars Market Size and Growth Rate of Antibody from 2014 to 2026

  • Figure Biologics and Biosimilars Market Size and Growth Rate of Hormone from 2014 to 2026

  • Figure Biologics and Biosimilars Market Size and Growth Rate of Growth Factors from 2014 to 2026

  • Figure Biologics and Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Biologics and Biosimilars Market Size and Growth Rate of Tumor from 2014 to 2026

  • Figure Global Biologics and Biosimilars Market Size and Growth Rate of Diabetes from 2014 to 2026

  • Figure Global Biologics and Biosimilars Market Size and Growth Rate of Cardiovascular from 2014 to 2026

  • Figure Global Biologics and Biosimilars Market Size and Growth Rate of Hemophilia from 2014 to 2026

  • Figure Global Biologics and Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Biologics and Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Biologics and Biosimilars Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Biologics and Biosimilars

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Biologics and Biosimilars by Different Types from 2014 to 2026

  • Table Consumption Share of Biologics and Biosimilars by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Antibody

  • Figure Market Size and Growth Rate of Hormone

  • Figure Market Size and Growth Rate of Growth Factors

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Biologics and Biosimilars by Different End-Users from 2014 to 2026

  • Table Consumption Share of Biologics and Biosimilars by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Tumor

  • Figure Market Size and Growth Rate of Diabetes

  • Figure Market Size and Growth Rate of Cardiovascular

  • Figure Market Size and Growth Rate of Hemophilia

  • Figure Market Size and Growth Rate of Others

  • Table Global Biologics and Biosimilars Production by Major Regions

  • Table Global Biologics and Biosimilars Production Share by Major Regions

  • Figure Global Biologics and Biosimilars Production Share by Major Regions in 2014

  • Figure Global Biologics and Biosimilars Production Share by Major Regions in 2018

  • Figure Global Biologics and Biosimilars Production Share by Major Regions in 2026

  • Table Global Biologics and Biosimilars Consumption by Major Regions

  • Table Global Biologics and Biosimilars Consumption Share by Major Regions

  • Figure Global Biologics and Biosimilars Consumption Share by Major Regions in 2014

  • Figure Global Biologics and Biosimilars Consumption Share by Major Regions in 2018

  • Figure Global Biologics and Biosimilars Consumption Share by Major Regions in 2026

  • Table North America Biologics and Biosimilars Production, Import, Consumption and Export Analysis

  • Table Europe Biologics and Biosimilars Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Biologics and Biosimilars Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Biologics and Biosimilars Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Biologics and Biosimilars market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Biologics and Biosimilars market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Biologics and Biosimilars market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Biologics and Biosimilars market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Biologics and Biosimilars Consumption by Types from 2014 to 2026

  • Table North America Biologics and Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure North America Biologics and Biosimilars Consumption Share by Types in 2014

  • Figure North America Biologics and Biosimilars Consumption Share by Types in 2018

  • Figure North America Biologics and Biosimilars Consumption Share by Types in 2026

  • Table North America Biologics and Biosimilars Consumption by End-Users from 2014 to 2026

  • Table North America Biologics and Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure North America Biologics and Biosimilars Consumption Share by End-Users in 2014

  • Figure North America Biologics and Biosimilars Consumption Share by End-Users in 2018

  • Figure North America Biologics and Biosimilars Consumption Share by End-Users in 2026

  • Table North America Biologics and Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table North America Biologics and Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Biologics and Biosimilars Consumption Share by Major Countries in 2014

  • Figure North America Biologics and Biosimilars Consumption Share by Major Countries in 2018

  • Figure North America Biologics and Biosimilars Consumption Share by Major Countries in 2026

  • Figure United States Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Biologics and Biosimilars Consumption by Types from 2014 to 2026

  • Table Europe Biologics and Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure Europe Biologics and Biosimilars Consumption Share by Types in 2014

  • Figure Europe Biologics and Biosimilars Consumption Share by Types in 2018

  • Figure Europe Biologics and Biosimilars Consumption Share by Types in 2026

  • Table Europe Biologics and Biosimilars Consumption by End-Users from 2014 to 2026

  • Table Europe Biologics and Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Biologics and Biosimilars Consumption Share by End-Users in 2014

  • Figure Europe Biologics and Biosimilars Consumption Share by End-Users in 2018

  • Figure Europe Biologics and Biosimilars Consumption Share by End-Users in 2026

  • Table Europe Biologics and Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table Europe Biologics and Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Biologics and Biosimilars Consumption Share by Major Countries in 2014

  • Figure Europe Biologics and Biosimilars Consumption Share by Major Countries in 2018

  • Figure Europe Biologics and Biosimilars Consumption Share by Major Countries in 2026

  • Figure Germany Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure France Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Biologics and Biosimilars Consumption by Types from 2014 to 2026

  • Table Asia Pacific Biologics and Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by Types in 2014

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by Types in 2018

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by Types in 2026

  • Table Asia Pacific Biologics and Biosimilars Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Biologics and Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by End-Users in 2014

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by End-Users in 2018

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by End-Users in 2026

  • Table Asia Pacific Biologics and Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Biologics and Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Biologics and Biosimilars Consumption Share by Major Countries in 2026

  • Figure China Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandBiologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure India Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Biologics and Biosimilars Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Biologics and Biosimilars Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Biologics and Biosimilars Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Biologics and Biosimilars Consumption Share by Major Countries in 2026

  • Figure GCC Countries Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Biologics and Biosimilars Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Roche

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

  • Figure Sales and Growth Rate Analysis of Roche

  • Figure Revenue and Market Share Analysis of Roche

  • Table Product and Service Introduction of Roche

  • Table Company Profile and Development Status of Amgen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

  • Figure Sales and Growth Rate Analysis of Amgen

  • Figure Revenue and Market Share Analysis of Amgen

  • Table Product and Service Introduction of Amgen

  • Table Company Profile and Development Status of AbbVie

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

  • Figure Sales and Growth Rate Analysis of AbbVie

  • Figure Revenue and Market Share Analysis of AbbVie

  • Table Product and Service Introduction of AbbVie

  • Table Company Profile and Development Status of Sanofi-Aventis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis

  • Figure Sales and Growth Rate Analysis of Sanofi-Aventis

  • Figure Revenue and Market Share Analysis of Sanofi-Aventis

  • Table Product and Service Introduction of Sanofi-Aventis

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Novo Nordisk

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

  • Figure Sales and Growth Rate Analysis of Novo Nordisk

  • Figure Revenue and Market Share Analysis of Novo Nordisk

  • Table Product and Service Introduction of Novo Nordisk

  • Table Company Profile and Development Status of Eli Lilly

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

  • Figure Sales and Growth Rate Analysis of Eli Lilly

  • Figure Revenue and Market Share Analysis of Eli Lilly

  • Table Product and Service Introduction of Eli Lilly

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of Merck

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

  • Figure Sales and Growth Rate Analysis of Merck

  • Figure Revenue and Market Share Analysis of Merck

  • Table Product and Service Introduction of Merck

  • Table Company Profile and Development Status of 3sbio

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3sbio

  • Figure Sales and Growth Rate Analysis of 3sbio

  • Figure Revenue and Market Share Analysis of 3sbio

  • Table Product and Service Introduction of 3sbio

  • Table Company Profile and Development Status of Changchun High Tech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High Tech

  • Figure Sales and Growth Rate Analysis of Changchun High Tech

  • Figure Revenue and Market Share Analysis of Changchun High Tech

  • Table Product and Service Introduction of Changchun High Tech

  • Table Company Profile and Development Status of CP Guojian

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian

  • Figure Sales and Growth Rate Analysis of CP Guojian

  • Figure Revenue and Market Share Analysis of CP Guojian

  • Table Product and Service Introduction of CP Guojian

  • Table Company Profile and Development Status of Biotech

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech

  • Figure Sales and Growth Rate Analysis of Biotech

  • Figure Revenue and Market Share Analysis of Biotech

  • Table Product and Service Introduction of Biotech

  • Table Company Profile and Development Status of Gelgen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gelgen

  • Figure Sales and Growth Rate Analysis of Gelgen

  • Figure Revenue and Market Share Analysis of Gelgen

  • Table Product and Service Introduction of Gelgen

  • Table Company Profile and Development Status of Innovent

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innovent

  • Figure Sales and Growth Rate Analysis of Innovent

  • Figure Revenue and Market Share Analysis of Innovent

  • Table Product and Service Introduction of Innovent

  • Table Company Profile and Development Status of Dong Bao

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dong Bao

  • Figure Sales and Growth Rate Analysis of Dong Bao

  • Figure Revenue and Market Share Analysis of Dong Bao

  • Table Product and Service Introduction of Dong Bao

  • Table Company Profile and Development Status of Ganlee

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ganlee

  • Figure Sales and Growth Rate Analysis of Ganlee

  • Figure Revenue and Market Share Analysis of Ganlee

  • Table Product and Service Introduction of Ganlee

  • Table Company Profile and Development Status of United Laboratories

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of United Laboratories

  • Figure Sales and Growth Rate Analysis of United Laboratories

  • Figure Revenue and Market Share Analysis of United Laboratories

  • Table Product and Service Introduction of United Laboratories


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top